BROSHY ERAN sold 39.8% of their position (29.50K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $590.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/1/2025ACC: 0001256230-25-000009
-15.50K
Net shares
Net seller
$590.0K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
14K acquired · 29.50K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−14K
Price / share
$20.00
Trade value
$280K
% of position
18.9%
11/26/2025
74.20K→60.20K
Ordinary Shares
Direct
Shares
−15.50K
Price / share
$20.00
Trade value
$310.02K
% of position
25.7%
11/26/2025
60.20K→44.70K
Total
Net shares
−29.50K
Net value
-$590.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/26/2025 | S · Sale | −14K | $20.00 | $280K | 18.9% | 74.20K | 60.20K |
| Ordinary Shares Direct | 11/26/2025 | S · Sale | −15.50K | $20.00 | $310.02K | 25.7% | 60.20K | 44.70K |
| Total | −29.50K | -$590.02K | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
14K shares
Shares
+14K
Strike price
10.15
Held after
81.75K
Exercisable
—
11/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares14K shares | 11/26/2025 | M · Option Exercise | +14K | 10.15 | — | 81.75K |